Rituxan and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Rituxan (rituximab), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Synthroid, and have Pain.

The phase IV clinical study analyzes which people have Panic attack when taking Rituxan. It is created by eHealthMe based on reports of 64,282 people who have side effects when taking Rituxan from the FDA, and is updated regularly.

What is Rituxan?

Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,790 Rituxan users. Check the latest studies of Rituxan.

What is Panic attack?

Panic attack is found to be associated with 2,532 drugs and 2,068 conditions by eHealthMe. Check the latest studies of Panic attack.

On Nov, 17, 2025

64,282 people reported to have side effects when taking Rituxan.
Among them, 91 people (0.14%) have Panic attack.

Among these 91 people:

How long have people been on Rituxan when they have Panic attack? *

What is the gender of people who have Panic attack when taking Rituxan? *

female: 91.86 %
male: 8.14 %

What is the age of people who have Panic attack when taking Rituxan? *

What are other drugs people take besides Rituxan? *

What are other side effects people have besides Panic attack? *

Dyspnea (difficult or laboured breathing): 58 people, 63.74%
Pain: 55 people, 60.44%
Joint Pain: 55 people, 60.44%
Fatigue (feeling of tiredness): 53 people, 58.24%
Stress And Anxiety: 52 people, 57.14%
Fever: 52 people, 57.14%
Weakness: 50 people, 54.95%
Nausea (feeling of having an urge to vomit): 49 people, 53.85%
Malaise (a feeling of general discomfort or uneasiness): 45 people, 49.45%
Nasopharyngitis (inflammation of the nasopharynx): 45 people, 49.45%

What are the existing conditions these people have? *

Pain: 16 people, 17.58%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 10 people, 10.99%
Sedation: 9 people, 9.89%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 5.49%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 5.49%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 3.30%
Post-Traumatic Stress Disorder: 3 people, 3.30%
Stress And Anxiety: 2 people, 2.20%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 2 people, 2.20%
Clinically Isolated Syndrome (individual's first neurological episode, caused by inflammation or demyelination of nerve tissue): 2 people, 2.20%

* Approximation only. Some reports may have incomplete information.

Do you take Rituxan and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rituxan:

Rituxan (64,790 reports)

Panic attack treatments and more:

Panic attack (65,702 reports)

Browse all side effects of Rituxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attack:

Panic attack (2,532 drugs)

Browse all the conditions that are associated with Panic attack:

Panic attack (2,068 conditions)

Drugs similar to Rituxan and Panic attack :

How the study uses the data?

The study uses data from the FDA. It is based on rituximab (the active ingredients of Rituxan) and Rituxan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.